ATEC

Alphatec Holdings, Inc. NASDAQ Listed Jun 12, 2006

Healthcare ·Medical - Devices ·US · atecspine.com

$7.72

Mkt Cap $1.2B

52w Low $6.85 5.3% of range 52w High $23.29

50d MA $11.52 200d MA $15.37

P/E (TTM) -10.9x

EV/EBITDA -91.1x

P/B 43.4x

Debt/Equity 17.2x

ROE -1153.7%

P/FCF 1137.4x

RSI (14) —

ATR (14) —

Beta 1.12

50d MA $11.52

200d MA $15.37

Avg Volume 2.7M

About

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualiza…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 5, 2026	AMC	-0.01	-0.22	-2100.0%	10.23	-21.7%	-31.7%	—	—	—	—	—
Feb 24, 2026	AMC	0.04	0.06	+50.0%	13.93	-4.8%	+0.8%	+0.6%	-2.2%	-3.3%	-6.5%	—
Oct 30, 2025	AMC	-0.03	0.03	+200.0%	16.33	+22.6%	+16.3%	+18.1%	+18.9%	+20.8%	+19.5%	—
Jul 31, 2025	AMC	-0.06	0.02	+133.3%	10.58	+13.2%	+30.2%	+40.5%	+45.0%	+43.7%	+40.8%	—
May 1, 2025	AMC	-0.12	-0.23	-91.7%	11.06	+4.0%	+8.5%	+8.3%	+10.0%	+12.6%	+15.2%	—
Feb 26, 2025	AMC	-0.19	-0.23	-21.1%	11.06	-5.1%	+9.6%	+13.3%	+10.9%	+6.1%	+3.4%	—
Oct 30, 2024	AMC	-0.27	-0.28	-3.7%	5.62	+24.2%	+39.7%	+44.3%	+48.8%	+52.7%	+57.8%	—
Jul 31, 2024	AMC	-0.26	-0.29	-11.5%	10.10	-21.8%	-34.3%	-37.6%	-35.1%	-35.7%	-39.6%	—
May 7, 2024	AMC	-0.33	-0.34	-3.0%	13.58	-14.3%	-21.9%	-16.5%	-15.2%	-18.0%	-20.0%	—
Feb 27, 2024	AMC	-0.28	-0.37	-32.1%	15.34	-5.7%	-8.9%	-12.5%	-12.5%	-12.1%	-14.1%	—
Nov 6, 2023	AMC	-0.30	-0.35	-16.7%	10.31	+6.7%	+5.2%	+2.5%	-1.8%	-1.1%	-3.6%	—
Aug 3, 2023	AMC	-0.30	-0.43	-43.3%	16.88	+0.7%	-5.6%	-4.4%	-9.1%	-11.0%	-11.4%	—
May 4, 2023	AMC	-0.32	-0.40	-25.0%	14.66	+4.0%	+3.4%	+1.3%	+4.1%	+6.4%	+2.7%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 9	Stifel	Maintains	Buy → Buy	—	$12.23	$11.99	-2.0%	+5.2%	+2.3%	+3.5%	+2.2%	+0.4%
Jan 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$22.65	$21.47	-5.2%	-22.3%	-27.4%	-29.6%	-22.9%	-21.7%
Jan 12	Needham	Maintains	Buy → Buy	—	$22.65	$21.47	-5.2%	-22.3%	-27.4%	-29.6%	-22.9%	-21.7%
Jan 7	Barclays	Maintains	Overweight → Overweight	—	$21.79	$22.02	+1.1%	+0.8%	+4.1%	+3.9%	-19.3%	-24.5%
Nov 10	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$19.80	$19.75	-0.3%	+2.2%	+4.6%	+4.8%	+2.0%	-0.3%
Nov 3	Barclays	Maintains	Overweight → Overweight	—	$18.99	$18.85	-0.7%	+1.6%	+2.3%	+3.8%	+2.7%	+4.3%
Oct 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$16.33	$20.02	+22.6%	+16.3%	+18.1%	+18.9%	+20.8%	+19.5%
Oct 31	Canaccord Genuity	Maintains	Buy → Buy	—	$16.33	$20.02	+22.6%	+16.3%	+18.1%	+18.9%	+20.8%	+19.5%
Oct 31	Stifel	Maintains	Buy → Buy	—	$16.33	$20.02	+22.6%	+16.3%	+18.1%	+18.9%	+20.8%	+19.5%
Oct 31	Piper Sandler	Maintains	Overweight → Overweight	—	$16.33	$20.02	+22.6%	+16.3%	+18.1%	+18.9%	+20.8%	+19.5%
Oct 31	Needham	Maintains	Buy → Buy	—	$16.33	$20.02	+22.6%	+16.3%	+18.1%	+18.9%	+20.8%	+19.5%
Oct 16	Wells Fargo	Maintains	Overweight → Overweight	—	$13.99	$14.13	+1.0%	+1.9%	+6.4%	+10.8%	+10.8%	+12.0%
Aug 4	Barclays	Maintains	Overweight → Overweight	—	$13.77	$13.98	+1.5%	+8.0%	+11.4%	+10.4%	+8.2%	+8.7%
Aug 1	Canaccord Genuity	Maintains	Buy → Buy	—	$10.58	$11.98	+13.2%	+30.2%	+40.5%	+45.0%	+43.7%	+40.8%
May 2	Needham	Maintains	Buy → Buy	—	$11.06	$11.50	+4.0%	+8.5%	+8.3%	+10.0%	+12.6%	+15.2%
May 2	Piper Sandler	Maintains	Overweight → Overweight	—	$11.06	$11.50	+4.0%	+8.5%	+8.3%	+10.0%	+12.6%	+15.2%
Apr 14	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.75	$10.01	+2.7%	+4.4%	+1.6%	+4.9%	+8.3%	+9.1%
Feb 27	Needham	Maintains	Buy → Buy	—	$11.06	$10.50	-5.1%	+9.6%	+13.3%	+10.9%	+6.1%	+3.4%
Feb 27	Piper Sandler	Maintains	Overweight → Overweight	—	$11.06	$10.50	-5.1%	+9.6%	+13.3%	+10.9%	+6.1%	+3.4%
Jan 22	Barclays	Maintains	Overweight → Overweight	—	$11.61	$11.57	-0.3%	-2.0%	+0.5%	-5.2%	-4.1%	-1.4%
Jan 14	HC Wainwright & Co.	Maintains	Buy → Buy	—	$10.88	$11.04	+1.5%	+2.2%	+4.3%	+3.8%	+6.3%	+6.7%
Jan 13	Needham	Maintains	Buy → Buy	—	$9.97	$10.40	+4.3%	+9.1%	+11.5%	+13.8%	+13.2%	+16.0%
Nov 19	Barclays	Maintains	Overweight → Overweight	—	$8.52	$8.52	+0.0%	+12.3%	+16.5%	+19.8%	+18.1%	+12.9%
Oct 31	Needham	Maintains	Buy → Buy	—	$5.62	$6.98	+24.2%	+39.7%	+44.3%	+48.8%	+52.7%	+57.8%
Oct 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.62	$6.98	+24.2%	+39.7%	+44.3%	+48.8%	+52.7%	+57.8%
Sep 3	Lake Street	Maintains	Buy → Buy	—	$6.90	$6.86	-0.6%	-1.4%	-2.2%	-3.6%	-7.0%	-18.1%
Aug 30	Canaccord Genuity	Maintains	Buy → Buy	—	$6.85	$6.88	+0.4%	+0.7%	-0.7%	-1.5%	-2.9%	-6.3%
Aug 22	Needham	Maintains	Buy → Buy	—	$5.68	$5.86	+3.2%	+0.2%	+1.1%	+4.6%	+11.3%	+10.0%
Aug 1	Wells Fargo	Maintains	Overweight → Overweight	—	$10.10	$7.90	-21.8%	-34.3%	-37.6%	-35.1%	-35.7%	-39.6%
Aug 1	Needham	Maintains	Buy → Buy	—	$10.10	$7.90	-21.8%	-34.3%	-37.6%	-35.1%	-35.7%	-39.6%
Aug 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$10.10	$7.90	-21.8%	-34.3%	-37.6%	-35.1%	-35.7%	-39.6%
Aug 1	Piper Sandler	Maintains	Overweight → Overweight	—	$10.10	$7.90	-21.8%	-34.3%	-37.6%	-35.1%	-35.7%	-39.6%
Aug 1	Stifel	Maintains	Buy → Buy	—	$10.10	$7.90	-21.8%	-34.3%	-37.6%	-35.1%	-35.7%	-39.6%
Jul 25	Canaccord Genuity	Maintains	Buy → Buy	—	$10.91	$10.81	-0.9%	-0.4%	+0.0%	-8.3%	-9.4%	-7.4%
Jul 15	Morgan Stanley	Maintains	Overweight → Overweight	—	$11.25	$11.31	+0.5%	+1.5%	+5.5%	+4.4%	-1.7%	-1.4%
Jul 11	Stifel	Maintains	Buy → Buy	—	$10.77	$10.92	+1.4%	+1.8%	+4.5%	+6.0%	+10.2%	+9.0%
May 8	Piper Sandler	Maintains	Overweight → Overweight	—	$13.58	$11.64	-14.3%	-21.9%	-16.5%	-15.2%	-18.0%	-20.0%
May 8	Needham	Maintains	Buy → Buy	—	$13.58	$11.64	-14.3%	-21.9%	-16.5%	-15.2%	-18.0%	-20.0%
Mar 28	Needham	Maintains	Buy → Buy	—	$13.80	$13.88	+0.6%	-0.1%	+1.2%	-2.2%	-2.2%	-3.0%
Mar 20	Canaccord Genuity	Maintains	Buy → Buy	—	$14.15	$14.65	+3.5%	-2.6%	-3.0%	-6.6%	-3.8%	-5.2%
Mar 20	Needham	Maintains	Buy → Buy	—	$14.15	$14.65	+3.5%	-2.6%	-3.0%	-6.6%	-3.8%	-5.2%
Mar 13	Needham	Maintains	Buy → Buy	—	$13.33	$13.45	+0.9%	+3.5%	+0.1%	-1.8%	+1.4%	+6.2%
Mar 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$13.42	$13.60	+1.3%	+0.5%	-1.8%	-3.0%	-3.9%	-4.6%
Feb 28	Needham	Maintains	Buy → Buy	—	$15.34	$14.46	-5.7%	-8.9%	-12.5%	-12.5%	-12.1%	-14.1%
Jan 22	Canaccord Genuity	Maintains	Buy → Buy	—	$15.44	$15.70	+1.7%	+3.0%	+3.6%	+3.0%	+4.5%	+5.2%
Dec 19	Needham	Maintains	Buy → Buy	—	$13.55	$13.94	+2.9%	+6.7%	+7.0%	+10.9%	+11.4%	+13.2%
Nov 14	Morgan Stanley	Maintains	Overweight → Overweight	—	$9.94	$10.36	+4.2%	+6.9%	+12.7%	+14.5%	+10.7%	+14.4%
Nov 7	Stifel	Maintains	Buy → Buy	—	$10.31	$11.00	+6.7%	+5.2%	+2.5%	-1.8%	-1.1%	-3.6%
Nov 7	Needham	Maintains	Buy → Buy	—	$10.31	$11.00	+6.7%	+5.2%	+2.5%	-1.8%	-1.1%	-3.6%
Aug 4	Needham	Maintains	Buy → Buy	—	$16.88	$16.99	+0.7%	-5.6%	-4.4%	-9.1%	-11.0%	-11.4%

Recent Filings

8-K · 1.02 !! High

Alphatec Holdings, Inc. -- 8-K 1.02: Material Agreement Terminated

I need more information to provide a specific analysis. The summary "Terminated Prior Credit" lacks details about the termination reason (breach, mutual agreement, expiration, or regulatory) and the credit facility's size/importance, making it impossible to assess investor implications accurately.

May 5

8-K · 5.02 !!! Very High

Alphatec Holdings, Inc. -- 8-K 5.02: Executive Change

Alphatec Holdings lost a board member and Compensation Committee participant, potentially affecting executive pay oversight and governance structure at the spine surgery company.

Mar 3

8-K

Alphatec Holdings, Inc. -- 8-K Filing

Alphatec Holdings reported 25% full-year 2025 revenue growth to $764 million with expanded profit margins, guiding 2026 revenue toward $890 million, demonstrating strong operational momentum.

Feb 24

Data updated apr 24, 2026 7:27pm · Source: massive.com